Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 241

1.

Correction: Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours.

Costa-Cabral S, Brough R, Konde A, Aarts M, Campbell J, Marinari E, Riffell J, Bardelli A, Torrance C, Lord CJ, Ashworth A.

PLoS One. 2018 Oct 26;13(10):e0206729. doi: 10.1371/journal.pone.0206729. eCollection 2018.

2.

Risk of diabetes after para-aortic radiation for testicular cancer.

Groot HJ, Gietema JA, Aleman BMP, Incrocci L, de Wit R, Witjes JA, Groenewegen G, de Brouwer P, Meijer OWM, Hulshof MCCM, van den Berg HA, Smilde TJ, Vanneste BGL, Aarts MJ, van den Bergh ACM, Kerst JM, van den Belt-Dusebout AW, Lubberts S, Jóźwiak K, Horenblas S, van Leeuwen FE, Schaapveld M.

Br J Cancer. 2018 Oct;119(7):901-907. doi: 10.1038/s41416-018-0248-x. Epub 2018 Oct 9.

PMID:
30297773
3.

Transcriptional effects of cadmium on iron homeostasis differ in calamine accessions of Noccaea caerulescens.

Halimaa P, Blande D, Baltzi E, Aarts MGM, Granlund L, Keinänen M, Kärenlampi SO, Kozhevnikova AD, Peräniemi S, Schat H, Seregin IV, Tuomainen M, Tervahauta AI.

Plant J. 2018 Oct 4. doi: 10.1111/tpj.14121. [Epub ahead of print]

PMID:
30288820
4.

Cadmium associates with oxalate in calcium oxalate crystals and competes with calcium for translocation to stems in the cadmium bioindicator Gomphrena claussenii.

Pongrac P, Serra TS, Castillo-Michel H, Vogel-Mikuš K, Arčon I, Kelemen M, Jenčič B, Kavčič A, Villafort Carvalho MT, Aarts MGM.

Metallomics. 2018 Nov 14;10(11):1576-1584. doi: 10.1039/c8mt00149a.

PMID:
30183791
5.

Author Correction: P53 and mTOR signalling determine fitness selection through cell competition during early mouse embryonic development.

Bowling S, Di Gregorio A, Sancho M, Pozzi S, Aarts M, Signore M, Schneider MD, Martinez-Barbera JP, Gil J, Rodríguez TA.

Nat Commun. 2018 Aug 2;9(1):3123. doi: 10.1038/s41467-018-05718-z.

6.

[Recent treatment results for metastatic melanoma: data from the Dutch Melanoma Treatment Registry].

van Zeijl MCT, van den Eertwegh AJM, Wouters MWJM, Jochems A, Schouwenburg MG, Haanen JBAG, Aarts MJ, van den Berkmortel FWPJ, de Groot JWB, Hospers GAP, Kapiteijn E, Koornstra RH, Piersma D, van Rijn RS, Suijkerbuijk KPM, Ten Tije AJ, van der Veldt AAM, Vreugdenhil G, van der Hoeven KJM.

Ned Tijdschr Geneeskd. 2018 Jun 15;162. pii: D2420. Dutch.

PMID:
30040270
7.

Changes in treatment patterns and survival in elderly patients with stage I non-small-cell lung cancer with the introduction of stereotactic body radiotherapy and video-assisted thoracic surgery.

Detillon DDEMA, Driessen EJM, Aarts MJ, Janssen-Heijnen MLG, van Eijck CHJ, Veen EJ.

Eur J Cancer. 2018 Sep;101:30-37. doi: 10.1016/j.ejca.2018.06.016. Epub 2018 Jul 14.

PMID:
30014972
8.

Risk of Solid Cancer After Treatment of Testicular Germ Cell Cancer in the Platinum Era.

Groot HJ, Lubberts S, de Wit R, Witjes JA, Kerst JM, de Jong IJ, Groenewegen G, van den Eertwegh AJM, Poortmans PM, Klümpen HJ, van den Berg HA, Smilde TJ, Vanneste BGL, Aarts MJ, Incrocci L, van den Bergh ACM, Jóźwiak K, van den Belt-Dusebout AW, Horenblas S, Gietema JA, van Leeuwen FE, Schaapveld M.

J Clin Oncol. 2018 Aug 20;36(24):2504-2513. doi: 10.1200/JCO.2017.77.4174. Epub 2018 Jul 10.

PMID:
29989856
9.

Epigenetics in renal cell cancer: mechanisms and clinical applications.

Joosten SC, Smits KM, Aarts MJ, Melotte V, Koch A, Tjan-Heijnen VC, van Engeland M.

Nat Rev Urol. 2018 Jul;15(7):430-451. doi: 10.1038/s41585-018-0023-z. Review.

PMID:
29867106
10.

mRNA expression of transient receptor potential melastatin (TRPM) channels 2 and 7 in perinatal brain development.

Ratnam M, Chan J, Lesani N, Sidorova-Darmos E, Eubanks JH, Aarts MM.

Int J Dev Neurosci. 2018 Oct;69:23-31. doi: 10.1016/j.ijdevneu.2018.05.008. Epub 2018 May 26.

PMID:
29842890
11.

Vemurafenib in BRAF-mutant metastatic melanoma patients in real-world clinical practice: prognostic factors associated with clinical outcomes.

Schouwenburg MG, Jochems A, Leeneman B, Franken MG, van den Eertwegh AJM, Haanen JBAG, van Zeijl MCT, Aarts MJ, van Akkooi ACJ, van den Berkmortel FWPJ, Blokx WAM, de Groot JWB, Hospers GAP, Kapiteijn E, Koornstra RH, Kruit WH, Louwman MWJ, Piersma D, van Rijn RS, Suijkerbuijk KPM, Ten Tije AJ, Vreugdenhil G, Wouters MWJM, van der Hoeven JJM.

Melanoma Res. 2018 Aug;28(4):326-332. doi: 10.1097/CMR.0000000000000453.

PMID:
29750749
12.

P53 and mTOR signalling determine fitness selection through cell competition during early mouse embryonic development.

Bowling S, Di Gregorio A, Sancho M, Pozzi S, Aarts M, Signore M, D Schneider M, Barbera JPM, Gil J, Rodríguez TA.

Nat Commun. 2018 May 2;9(1):1763. doi: 10.1038/s41467-018-04167-y. Erratum in: Nat Commun. 2018 Aug 2;9(1):3123.

13.

Real-world use, safety, and survival of ipilimumab in metastatic cutaneous melanoma in The Netherlands.

Jochems A, Leeneman B, Franken MG, Schouwenburg MG, Aarts MJB, van Akkooi ACJ, van den Berkmortel FWPJ, van den Eertwegh AJM, Groenewegen G, de Groot JWB, Haanen JBAG, Hospers GAP, Kapiteijn E, Koornstra RH, Kruit WHJ, Louwman MWJ, Piersma D, van Rijn RS, Ten Tije AJ, Vreugdenhil G, Wouters MWJM, Uyl-de Groot CA, van der Hoeven KJM.

Anticancer Drugs. 2018 Jul;29(6):572-578. doi: 10.1097/CAD.0000000000000629.

PMID:
29659371
14.

Towards a uniform specification of light therapy devices for the treatment of affective disorders and use for non-image forming effects: Radiant flux.

Aarts MPJ, Rosemann ALP.

J Affect Disord. 2018 Aug 1;235:142-149. doi: 10.1016/j.jad.2018.04.020. Epub 2018 Apr 5.

PMID:
29656258
15.

Real-world healthcare costs of ipilimumab in patients with advanced cutaneous melanoma in The Netherlands.

Franken MG, Leeneman B, Jochems A, Schouwenburg MG, Aarts MJB, van Akkooi ACJ, van den Berkmortel FWPJ, van den Eertwegh AJM, de Groot JWB, van der Hoeven KJM, Hospers GAP, Kapiteijn E, Koornstra R, Kruit WHJ, Louwman MWJ, Piersma D, van Rijn RS, Suijkerbuijk KPM, Ten Tije AJ, Vreugdenhil G, Wouters MWJM, van Zeijl M, Haanen JBAG, Uyl-de Groot CA.

Anticancer Drugs. 2018 Jul;29(6):579-588. doi: 10.1097/CAD.0000000000000628.

PMID:
29634490
16.

LPCAT1 controls phosphate homeostasis in a zinc-dependent manner.

Kisko M, Bouain N, Safi A, Medici A, Akkers RC, Secco D, Fouret G, Krouk G, Aarts MG, Busch W, Rouached H.

Elife. 2018 Feb 17;7. pii: e32077. doi: 10.7554/eLife.32077.

17.

Patterns of treatment and survival among older patients with stage III non-small cell lung cancer.

Driessen EJM, Schulkes KJG, Dingemans AC, van Loon JGM, Hamaker ME, Aarts MJ, Janssen-Heijnen MLG.

Lung Cancer. 2018 Feb;116:55-61. doi: 10.1016/j.lungcan.2017.12.013. Epub 2017 Dec 20.

PMID:
29413051
18.

Postoperative ERAS Interventions Have the Greatest Impact on Optimal Recovery: Experience With Implementation of ERAS Across Multiple Hospitals.

Aarts MA, Rotstein OD, Pearsall EA, Victor JC, Okrainec A, McKenzie M, McCluskey SA, Conn LG, McLeod RS; iERAS group.

Ann Surg. 2018 Jun;267(6):992-997. doi: 10.1097/SLA.0000000000002632.

PMID:
29303803
19.

Association of socioeconomic status with outcomes in older adult community-dwelling patients after visiting the emergency department: a retrospective cohort study.

Wachelder JJH, van Drunen I, Stassen PM, Brouns SHA, Lambooij SLE, Aarts MJ, Haak HR.

BMJ Open. 2017 Dec 26;7(12):e019318. doi: 10.1136/bmjopen-2017-019318.

20.

Local Fitness Landscapes Predict Yeast Evolutionary Dynamics in Directionally Changing Environments.

Gorter FA, Aarts MGM, Zwaan BJ, de Visser JAGM.

Genetics. 2018 Jan;208(1):307-322. doi: 10.1534/genetics.117.300519. Epub 2017 Nov 15.

PMID:
29141909
21.

Coupling shRNA screens with single-cell RNA-seq identifies a dual role for mTOR in reprogramming-induced senescence.

Aarts M, Georgilis A, Beniazza M, Beolchi P, Banito A, Carroll T, Kulisic M, Kaemena DF, Dharmalingam G, Martin N, Reik W, Zuber J, Kaji K, Chandra T, Gil J.

Genes Dev. 2017 Oct 15;31(20):2085-2098. doi: 10.1101/gad.297796.117. Epub 2017 Nov 14.

22.

Natural variation of YELLOW SEEDLING1 affects photosynthetic acclimation of Arabidopsis thaliana.

van Rooijen R, Kruijer W, Boesten R, van Eeuwijk FA, Harbinson J, Aarts MGM.

Nat Commun. 2017 Nov 10;8(1):1421. doi: 10.1038/s41467-017-01576-3.

23.

Genomics of Adaptation Depends on the Rate of Environmental Change in Experimental Yeast Populations.

Gorter FA, Derks MFL, van den Heuvel J, Aarts MGM, Zwaan BJ, de Ridder D, de Visser JAGM.

Mol Biol Evol. 2017 Oct 1;34(10):2613-2626. doi: 10.1093/molbev/msx185.

PMID:
28957501
24.

Emergency Room Visits and Readmissions Following Implementation of an Enhanced Recovery After Surgery (iERAS) Program.

Wood T, Aarts MA, Okrainec A, Pearsall E, Victor JC, McKenzie M, Rotstein O, McLeod RS; iERAS group.

J Gastrointest Surg. 2018 Feb;22(2):259-266. doi: 10.1007/s11605-017-3555-2. Epub 2017 Sep 15.

PMID:
28916971
25.

Immortal time bias in pharmacoepidemiological studies on cancer patient survival: empirical illustration for beta-blocker use in four cancers with different prognosis.

Weberpals J, Jansen L, van Herk-Sukel MPP, Kuiper JG, Aarts MJ, Vissers PAJ, Brenner H.

Eur J Epidemiol. 2017 Nov;32(11):1019-1031. doi: 10.1007/s10654-017-0304-5. Epub 2017 Sep 1.

PMID:
28864947
26.

Natural variation in Arabidopsis thaliana reveals shoot ionome, biomass, and gene expression changes as biomarkers for zinc deficiency tolerance.

Campos ACAL, Kruijer W, Alexander R, Akkers RC, Danku J, Salt DE, Aarts MGM.

J Exp Bot. 2017 Jun 15;68(13):3643-3656. doi: 10.1093/jxb/erx191.

PMID:
28859376
27.

Neutrophil Recovery in Breast Cancer Patients Receiving Docetaxel-Containing Chemotherapy with and without Granulocyte Colony-Stimulating Factor Prophylaxis.

Aarts MJ, Vriens BE, de Boer M, Peters FP, Mandigers CM, Dercksen MW, Stouthard JM, Tol J, van Warmerdam LJ, van de Wouw AJ, Jacobs EM, van der Rijt CCD, Smilde TJ, van der Velden AW, Peer N, Tjan-Heijnen VCG.

Oncology. 2017;93(5):323-328. doi: 10.1159/000479067. Epub 2017 Aug 22.

PMID:
28848182
28.

Prognostic DNA methylation markers for renal cell carcinoma: a systematic review.

Joosten SC, Deckers IA, Aarts MJ, Hoeben A, van Roermund JG, Smits KM, Melotte V, van Engeland M, Tjan-Heijnen VC.

Epigenomics. 2017 Sep;9(9):1243-1257. doi: 10.2217/epi-2017-0040. Epub 2017 Aug 14. Review.

29.

Improved survival for sequentially as opposed to concurrently delivered neoadjuvant chemotherapy in non-metastatic breast cancer.

Vriens BEPJ, Vriens IJH, Aarts MJB, van Gastel SM, van den Berkmortel FWPJ, Smilde TJ, van Warmerdam LJC, van Spronsen DJ, Peer PGM, de Boer M, Tjan-Heijnen VCG; Breast Cancer Trialists’ Group of the Netherlands (BOOG).

Breast Cancer Res Treat. 2017 Oct;165(3):593-600. doi: 10.1007/s10549-017-4364-8. Epub 2017 Jul 3.

30.

Trends in treatment and relative survival among Non-Small Cell Lung Cancer patients in the Netherlands (1990-2014): Disparities between younger and older patients.

Driessen EJ, Aarts MJ, Bootsma GP, van Loon JG, Janssen-Heijnen ML.

Lung Cancer. 2017 Jun;108:198-204. doi: 10.1016/j.lungcan.2017.04.005. Epub 2017 Apr 10.

PMID:
28625635
31.

Compliance with Urinary Catheter Removal Guidelines Leads to Improved Outcome in Enhanced Recovery After Surgery Patients.

Okrainec A, Aarts MA, Conn LG, McCluskey S, McKenzie M, Pearsall EA, Rotstein O, Victor JC, McLeod RS; members of the iERAS Group.

J Gastrointest Surg. 2017 Aug;21(8):1309-1317. doi: 10.1007/s11605-017-3434-x. Epub 2017 May 25.

PMID:
28547632
32.

Genome-Wide Identification, Cloning and Functional Analysis of the Zinc/Iron-Regulated Transporter-Like Protein (ZIP) Gene Family in Trifoliate Orange (Poncirus trifoliata L. Raf.).

Fu XZ, Zhou X, Xing F, Ling LL, Chun CP, Cao L, Aarts MGM, Peng LZ.

Front Plant Sci. 2017 Apr 19;8:588. doi: 10.3389/fpls.2017.00588. eCollection 2017.

33.

Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours.

Costa-Cabral S, Brough R, Konde A, Aarts M, Campbell J, Marinari E, Riffell J, Bardelli A, Torrance C, Lord CJ, Ashworth A.

PLoS One. 2017 Apr 20;12(4):e0176578. doi: 10.1371/journal.pone.0176578. eCollection 2017. Erratum in: PLoS One. 2018 Oct 26;13(10):e0206729.

34.

Timed Get Up and Go Test and Geriatric 8 Scores and the Association With (Chemo-)Radiation Therapy Noncompliance and Acute Toxicity in Elderly Cancer Patients.

Middelburg JG, Mast ME, de Kroon M, Jobsen JJ, Rozema T, Maas H, Baartman EA, Geijsen D, van der Leest AH, van den Bongard DJ, van Loon J, Budiharto T, Coebergh JW, Aarts MJ, Struikmans H; LPRO (Dutch National Organization for Radiotherapy in the Elderly).

Int J Radiat Oncol Biol Phys. 2017 Jul 15;98(4):843-849. doi: 10.1016/j.ijrobp.2017.01.211. Epub 2017 Jan 29.

PMID:
28366575
35.

Axillary staging in breast cancer patients treated with neoadjuvant chemotherapy in two Dutch phase III studies.

Vriens BEPJ, Keymeulen KBMI, Kroep JR, Charehbili A, Peer PG, de Boer M, Aarts MJB, Heuts EM, Tjan-Heijnen VCG; Dutch Breast Cancer Research Group (BOOG).

Oncotarget. 2017 Jul 11;8(28):46557-46564. doi: 10.18632/oncotarget.15101.

36.

De novo transcriptome assemblies of four accessions of the metal hyperaccumulator plant Noccaea caerulescens.

Blande D, Halimaa P, Tervahauta AI, Aarts MG, Kärenlampi SO.

Sci Data. 2017 Jan 31;4:160131. doi: 10.1038/sdata.2016.131.

37.

The correlation of age with chemotherapy-induced ovarian function failure in breast cancer patients.

Vriens IJ, De Bie AJ, Aarts MJ, de Boer M, van Hellemond IE, Roijen JH, van Golde RJ, Voogd AC, Tjan-Heijnen VC.

Oncotarget. 2017 Feb 14;8(7):11372-11379. doi: 10.18632/oncotarget.14532.

38.

Phase Transitions in Spin-Crossover Thin Films Probed by Graphene Transport Measurements.

Dugay J, Aarts M, Giménez-Marqués M, Kozlova T, Zandbergen HW, Coronado E, van der Zant HS.

Nano Lett. 2017 Jan 11;17(1):186-193. doi: 10.1021/acs.nanolett.6b03780. Epub 2016 Dec 7.

PMID:
28073272
39.

The distress thermometer as a predictor for survival in stage III lung cancer patients treated with chemotherapy.

de Mol M, den Oudsten BL, Aarts M, Aerts JGJV.

Oncotarget. 2017 May 30;8(22):36743-36749. doi: 10.18632/oncotarget.14151.

40.

Dutch Melanoma Treatment Registry: Quality assurance in the care of patients with metastatic melanoma in the Netherlands.

Jochems A, Schouwenburg MG, Leeneman B, Franken MG, van den Eertwegh AJ, Haanen JB, Gelderblom H, Uyl-de Groot CA, Aarts MJ, van den Berkmortel FW, Blokx WA, Cardous-Ubbink MC, Groenewegen G, de Groot JW, Hospers GA, Kapiteijn E, Koornstra RH, Kruit WH, Louwman MW, Piersma D, van Rijn RS, Ten Tije AJ, Vreugdenhil G, Wouters MW, van der Hoeven JJ.

Eur J Cancer. 2017 Feb;72:156-165. doi: 10.1016/j.ejca.2016.11.021. Epub 2016 Dec 25.

PMID:
28030784
41.

[Vismodegib for basal cell carcinoma: targeted therapy in case of locally advanced or metastasised disease].

Reinders MG, Terra JB, Reyners AK, Aarts MJ, de Haas ER, Mosterd K.

Ned Tijdschr Geneeskd. 2016;160:D187. Dutch.

PMID:
28000572
42.

Alternating Treatment With Pazopanib and Everolimus vs Continuous Pazopanib to Delay Disease Progression in Patients With Metastatic Clear Cell Renal Cell Cancer: The ROPETAR Randomized Clinical Trial.

Cirkel GA, Hamberg P, Sleijfer S, Loosveld OJL, Dercksen MW, Los M, Polee MB, van den Berkmortel F, Aarts MJ, Beerepoot LV, Groenewegen G, Lolkema MP, Tascilar M, Portielje JEA, Peters FPJ, Klümpen HJ, van der Noort V, Haanen JBAG, Voest EE; Dutch WIN-O Consortium.

JAMA Oncol. 2017 Apr 1;3(4):501-508. doi: 10.1001/jamaoncol.2016.5202.

PMID:
27918762
43.

A Four-Gene Promoter Methylation Marker Panel Consisting of GREM1, NEURL, LAD1, and NEFH Predicts Survival of Clear Cell Renal Cell Cancer Patients.

van Vlodrop IJH, Joosten SC, De Meyer T, Smits KM, Van Neste L, Melotte V, Baldewijns MMLL, Schouten LJ, van den Brandt PA, Jeschke J, Yi JM, Schuebel KE, Ahuja N, Herman JG, Aarts MJ, Bosman FT, Van Criekinge W, van Engeland M.

Clin Cancer Res. 2017 Apr 15;23(8):2006-2018. doi: 10.1158/1078-0432.CCR-16-1236. Epub 2016 Oct 18.

44.

Promoter CpG island methylation in ion transport mechanisms and associated dietary intakes jointly influence the risk of clear-cell renal cell cancer.

Deckers IA, van Engeland M, van den Brandt PA, Van Neste L, Soetekouw PM, Aarts MJ, Baldewijns MM, Keszei AP, Schouten LJ.

Int J Epidemiol. 2017 Apr 1;46(2):622-631. doi: 10.1093/ije/dyw266.

PMID:
27789672
45.

Cost-effectiveness of obinutuzumab for chronic lymphocytic leukaemia in The Netherlands.

Blommestein HM, de Groot S, Aarts MJ, Vemer P, de Vries R, van Abeelen AF, Posthuma EF, Uyl-de Groot CA.

Leuk Res. 2016 Nov;50:37-45. doi: 10.1016/j.leukres.2016.09.005. Epub 2016 Sep 3.

46.

Genetic architecture of plant stress resistance: multi-trait genome-wide association mapping.

Thoen MP, Davila Olivas NH, Kloth KJ, Coolen S, Huang PP, Aarts MG, Bac-Molenaar JA, Bakker J, Bouwmeester HJ, Broekgaarden C, Bucher J, Busscher-Lange J, Cheng X, Fradin EF, Jongsma MA, Julkowska MM, Keurentjes JJ, Ligterink W, Pieterse CM, Ruyter-Spira C, Smant G, Testerink C, Usadel B, van Loon JJ, van Pelt JA, van Schaik CC, van Wees SC, Visser RG, Voorrips R, Vosman B, Vreugdenhil D, Warmerdam S, Wiegers GL, van Heerwaarden J, Kruijer W, van Eeuwijk FA, Dicke M.

New Phytol. 2017 Feb;213(3):1346-1362. doi: 10.1111/nph.14220. Epub 2016 Oct 4.

47.

Recommendations for measuring non-image-forming effects of light: A practical method to apply on cognitive impaired and unaffected participants.

van Duijnhoven J, Aarts MP, Aries MB, Böhmer MN, Rosemann AL.

Technol Health Care. 2017;25(2):171-186. doi: 10.3233/THC-161258.

PMID:
27689558
48.

Optimizing Bariatric Surgery Multidisciplinary Follow-up: a Focus on Patient-Centered Care.

Aarts MA, Sivapalan N, Nikzad SE, Serodio K, Sockalingam S, Conn LG.

Obes Surg. 2017 Mar;27(3):730-736. doi: 10.1007/s11695-016-2354-2.

PMID:
27599986
49.

Multi-Element Bioimaging of Arabidopsis thaliana Roots.

Persson DP, Chen A, Aarts MG, Salt DE, Schjoerring JK, Husted S.

Plant Physiol. 2016 Oct;172(2):835-847. Epub 2016 Aug 26.

50.

Enzalutamide as a Fourth- or Fifth-Line Treatment Option for Metastatic Castration-Resistant Prostate Cancer.

Badrising SK, van der Noort V, Hamberg P, Coenen JL, Aarts MJ, van Oort IM, van den Eertwegh AJ, Los M, van den Berg HP, Gelderblom H, Vrijaldenhoven S, Kerver ED, van Voorthuizen T, de Jong IJ, Haanen JB, Bergman AM; Dutch Uro-Oncology Study Group (DUOS).

Oncology. 2016;91(5):267-273. Epub 2016 Aug 20.

PMID:
27544669

Supplemental Content

Support Center